nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan
|
Bernardo, Maria Ester |
|
|
120 |
2 |
p. 473-476 |
artikel |
2 |
A perspective on the selection of unrelated donors and cord blood units for transplantation
|
Spellman, Stephen R. |
|
|
120 |
2 |
p. 259-265 |
artikel |
3 |
APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair
|
Nowarski, Roni |
|
|
120 |
2 |
p. 366-375 |
artikel |
4 |
Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
|
Messinger, Yoav H. |
|
|
120 |
2 |
p. 285-290 |
artikel |
5 |
Calpain inhibition stabilizes the platelet proteome and reactivity in diabetes
|
Randriamboavonjy, Voahanginirina |
|
|
120 |
2 |
p. 415-423 |
artikel |
6 |
CDP-diacylglycerol synthetase-controlled phosphoinositide availability limits VEGFA signaling and vascular morphogenesis
|
Pan, Weijun |
|
|
120 |
2 |
p. 489-498 |
artikel |
7 |
Crystal structures of protease nexin-1 in complex with heparin and thrombin suggest a 2-step recognition mechanism
|
Li, Wei |
|
|
120 |
2 |
p. 459-467 |
artikel |
8 |
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
|
Leung, Wing |
|
|
120 |
2 |
p. 468-472 |
artikel |
9 |
Drug response in a genetically engineered mouse model of multiple myeloma is predictive of clinical efficacy
|
Chesi, Marta |
|
|
120 |
2 |
p. 376-385 |
artikel |
10 |
Dual actions of Meis1 inhibit erythroid progenitor development and sustain general hematopoietic cell proliferation
|
Cai, Mi |
|
|
120 |
2 |
p. 335-346 |
artikel |
11 |
Editorial Board
|
|
|
|
120 |
2 |
p. i |
artikel |
12 |
Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation
|
Roth, Michael |
|
|
120 |
2 |
p. 386-394 |
artikel |
13 |
Essential role of TAK1 in regulating mantle cell lymphoma survival
|
Buglio, Daniela |
|
|
120 |
2 |
p. 347-355 |
artikel |
14 |
FANCL ubiquitinates β-catenin and enhances its nuclear function
|
Dao, Kim-Hien T. |
|
|
120 |
2 |
p. 323-334 |
artikel |
15 |
Forecasting the future for patients with hereditary TTP
|
George, James N. |
|
|
120 |
2 |
p. 243-244 |
artikel |
16 |
GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia
|
Greif, Philipp A. |
|
|
120 |
2 |
p. 395-403 |
artikel |
17 |
GFI1 and GFI1B control the loss of endothelial identity of hemogenic endothelium during hematopoietic commitment
|
Lancrin, Christophe |
|
|
120 |
2 |
p. 314-322 |
artikel |
18 |
Hedgehog signaling via a calcitonin receptor-like receptor can induce arterial differentiation independently of VEGF signaling in zebrafish
|
Wilkinson, Robert N. |
|
|
120 |
2 |
p. 477-488 |
artikel |
19 |
How I treat polycythemia vera
|
Passamonti, Francesco |
|
|
120 |
2 |
p. 275-284 |
artikel |
20 |
Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling
|
Besson-Fournier, Céline |
|
|
120 |
2 |
p. 431-439 |
artikel |
21 |
Leukemic phase of Burkitt lymphoma
|
Munoz, Javier |
|
|
120 |
2 |
p. 247 |
artikel |
22 |
miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia
|
Eisfeld, Ann-Kathrin |
|
|
120 |
2 |
p. 249-258 |
artikel |
23 |
Mouse models can predict cancer therapy
|
Kuehl, W. Michael |
|
|
120 |
2 |
p. 238-240 |
artikel |
24 |
N-cadherin in osteolineage cells is not required for maintenance of hematopoietic stem cells
|
Greenbaum, Adam M. |
|
|
120 |
2 |
p. 295-302 |
artikel |
25 |
N(o)-cadherin role for HSCs
|
Levesque, Jean-Pierre |
|
|
120 |
2 |
p. 237-238 |
artikel |
26 |
Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells
|
Bromberg, Olga |
|
|
120 |
2 |
p. 303-313 |
artikel |
27 |
Predictive value of early molecular response in patients with chronic myeloid leukemia treated with first-line dasatinib
|
Marin, David |
|
|
120 |
2 |
p. 291-294 |
artikel |
28 |
Pretransplant MRD: the light is yellow, not red
|
Wayne, Alan S. |
|
|
120 |
2 |
p. 244-246 |
artikel |
29 |
Quantitative assessment of sensing and sequestration of spherocytic erythrocytes by the human spleen
|
Safeukui, Innocent |
|
|
120 |
2 |
p. 424-430 |
artikel |
30 |
Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura
|
Lotta, Luca A. |
|
|
120 |
2 |
p. 440-448 |
artikel |
31 |
Sequence and structure relationships within von Willebrand factor
|
Zhou, Yan-Feng |
|
|
120 |
2 |
p. 449-458 |
artikel |
32 |
SLC35D3 delivery from megakaryocyte early endosomes is required for platelet dense granule biogenesis and is differentially defective in Hermansky-Pudlak syndrome models
|
Meng, Ronghua |
|
|
120 |
2 |
p. 404-414 |
artikel |
33 |
Small gene, big number, many effects
|
Calin, George A. |
|
|
120 |
2 |
p. 240-241 |
artikel |
34 |
The degree of BCR and NFAT activation predicts clinical outcomes in chronic lymphocytic leukemia
|
Le Roy, Christine |
|
|
120 |
2 |
p. 356-365 |
artikel |
35 |
The significance of autoantibodies against β2-glycoprotein I
|
de Groot, Philip G. |
|
|
120 |
2 |
p. 266-274 |
artikel |
36 |
What does the spleen see?
|
Schrier, Stanley L. |
|
|
120 |
2 |
p. 242-243 |
artikel |